For example, the rivastigmine patch (Exelon) SmPC specifies application to the upper or lower back, upper arm, or chest, while certain hormone replacement therapy patches have different site recommendations
NICE recommend tirzepatide and semaglutide for patients with at least one weight-related comorbidity and a BMI 35 kg/m 2 (or BMI 30 kg/m 2 and who meet the criteria for referral to specialist weight management services, for semaglutide only) and liraglutide for patients with a BMI 35 kg/m 2 , non-diabetic hyperglycaemia, and a high risk of cardiovascular disease
p -value 0.1547]), and exenatide (RR 6.5609 [95% CI 0.8253, 52.1544
For more on mood-related support, see: Nootropics for neurotransmitters and anti-anxiety nootropic stack
Experts caution, however, that the findings are observational and do not prove causation
D., Hoppel, C